Arbutus Biopharma Corporation
Revenue Breakdown
| Fiscal Year | Collaborations and Licenses Revenue | Non-cash Royalty Revenue |
|---|---|---|
| FY2023 | $14.3M | $3.9M |
| FY2024 | $3.9M | $2.3M |
| FY2025 | $12.6M | $1.5M |
Revenue Breakdown
| Fiscal Year | Collaborations and Licenses Revenue | Non-cash Royalty Revenue |
|---|---|---|
| FY2023 | $14.3M | $3.9M |
| FY2024 | $3.9M | $2.3M |
| FY2025 | $12.6M | $1.5M |